Letter: Cytokeratin-18 as a Biomarker of Hepatocellular Carcinoma Regression After Transarterial Chemoembolization. Authors’ Reply
Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.13826
Full Text
Open PDFAbstract
Available in full text
Date
December 2, 2016
Authors
Publisher
Wiley